vs
Side-by-side financial comparison of COLLEGIUM PHARMACEUTICAL, INC (COLL) and NOODLES & Co (NDLS). Click either name above to swap in a different company.
COLLEGIUM PHARMACEUTICAL, INC is the larger business by last-quarter revenue ($205.4M vs $122.1M, roughly 1.7× NOODLES & Co). COLLEGIUM PHARMACEUTICAL, INC runs the higher net margin — 8.3% vs -7.5%, a 15.8% gap on every dollar of revenue. On growth, COLLEGIUM PHARMACEUTICAL, INC posted the faster year-over-year revenue change (12.9% vs -4.1%). COLLEGIUM PHARMACEUTICAL, INC produced more free cash flow last quarter ($122.4M vs $-2.8M). Over the past eight quarters, COLLEGIUM PHARMACEUTICAL, INC's revenue compounded faster (19.1% CAGR vs -1.2%).
Collegium Pharmaceutical, Inc. is a specialty pharmaceutical firm focused on developing and commercializing innovative, abuse-deterrent pain management therapies. Operating primarily in the U.S. market, it offers extended-release analgesics for chronic pain patients, serving providers across primary and specialty care segments.
Noodles & Company is an American fast-casual restaurant that offers international and American noodle dishes in addition to soups and salads. Noodles & Company was founded in 1995 by Aaron Kennedy and is headquartered in Broomfield, Colorado. The company went public in 2013 and recorded a $457 million revenue in 2017. In mid-2022, there were 458 Noodles & Company locations across 31 states.
COLL vs NDLS — Head-to-Head
Income Statement — Q4 FY2025 vs Q3 FY2025
| Metric | | |
|---|---|---|
| Revenue | $205.4M | $122.1M |
| Net Profit | $17.0M | $-9.2M |
| Gross Margin | 62.5% | — |
| Operating Margin | 29.6% | -5.2% |
| Net Margin | 8.3% | -7.5% |
| Revenue YoY | 12.9% | -4.1% |
| Net Profit YoY | 35.3% | 32.8% |
| EPS (diluted) | $0.48 | $-0.20 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $205.4M | — | ||
| Q3 25 | $209.4M | $122.1M | ||
| Q2 25 | $188.0M | $123.8M | ||
| Q1 25 | $177.8M | — | ||
| Q4 24 | $181.9M | $122.8M | ||
| Q3 24 | $159.3M | $127.4M | ||
| Q2 24 | $145.3M | $121.4M | ||
| Q1 24 | $144.9M | $124.3M |
| Q4 25 | $17.0M | — | ||
| Q3 25 | $31.5M | $-9.2M | ||
| Q2 25 | $12.0M | $-9.1M | ||
| Q1 25 | $2.4M | — | ||
| Q4 24 | $12.5M | $-6.8M | ||
| Q3 24 | $9.3M | $-13.6M | ||
| Q2 24 | $19.6M | $-6.1M | ||
| Q1 24 | $27.7M | $-6.1M |
| Q4 25 | 62.5% | — | ||
| Q3 25 | 61.7% | — | ||
| Q2 25 | 57.7% | — | ||
| Q1 25 | 54.8% | — | ||
| Q4 24 | 54.0% | — | ||
| Q3 24 | 60.8% | — | ||
| Q2 24 | 62.5% | — | ||
| Q1 24 | 63.1% | — |
| Q4 25 | 29.6% | — | ||
| Q3 25 | 29.7% | -5.2% | ||
| Q2 25 | 18.7% | -5.2% | ||
| Q1 25 | 12.2% | — | ||
| Q4 24 | 20.9% | -3.9% | ||
| Q3 24 | 21.9% | -9.0% | ||
| Q2 24 | 32.7% | -3.4% | ||
| Q1 24 | 34.1% | -3.7% |
| Q4 25 | 8.3% | — | ||
| Q3 25 | 15.0% | -7.5% | ||
| Q2 25 | 6.4% | -7.3% | ||
| Q1 25 | 1.4% | — | ||
| Q4 24 | 6.9% | -5.5% | ||
| Q3 24 | 5.9% | -10.7% | ||
| Q2 24 | 13.5% | -5.1% | ||
| Q1 24 | 19.1% | -4.9% |
| Q4 25 | $0.48 | — | ||
| Q3 25 | $0.84 | $-0.20 | ||
| Q2 25 | $0.34 | $-0.20 | ||
| Q1 25 | $0.07 | — | ||
| Q4 24 | $0.36 | $-0.15 | ||
| Q3 24 | $0.27 | $-0.30 | ||
| Q2 24 | $0.52 | $-0.14 | ||
| Q1 24 | $0.71 | $-1.64 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $386.7M | $4.7M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $301.7M | $-38.9M |
| Total Assets | $1.7B | $280.6M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $386.7M | — | ||
| Q3 25 | $285.9M | $4.7M | ||
| Q2 25 | $222.2M | $1.4M | ||
| Q1 25 | $197.8M | — | ||
| Q4 24 | $162.8M | $3.3M | ||
| Q3 24 | $120.0M | $1.8M | ||
| Q2 24 | $271.6M | $1.3M | ||
| Q1 24 | $318.0M | $3.0M |
| Q4 25 | $301.7M | — | ||
| Q3 25 | $274.8M | $-38.9M | ||
| Q2 25 | $232.2M | $-13.9M | ||
| Q1 25 | $234.4M | — | ||
| Q4 24 | $228.8M | $3.7M | ||
| Q3 24 | $234.3M | $9.6M | ||
| Q2 24 | $216.6M | $21.9M | ||
| Q1 24 | $222.2M | $27.2M |
| Q4 25 | $1.7B | — | ||
| Q3 25 | $1.6B | $280.6M | ||
| Q2 25 | $1.6B | $319.4M | ||
| Q1 25 | $1.6B | — | ||
| Q4 24 | $1.7B | $340.5M | ||
| Q3 24 | $1.6B | $346.3M | ||
| Q2 24 | $1.1B | $360.4M | ||
| Q1 24 | $1.1B | $368.1M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $123.0M | $4.3M |
| Free Cash FlowOCF − Capex | $122.4M | $-2.8M |
| FCF MarginFCF / Revenue | 59.6% | -2.3% |
| Capex IntensityCapex / Revenue | 0.3% | 5.8% |
| Cash ConversionOCF / Net Profit | 7.25× | — |
| TTM Free Cash FlowTrailing 4 quarters | $327.6M | $-7.5M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $123.0M | — | ||
| Q3 25 | $78.4M | $4.3M | ||
| Q2 25 | $72.4M | $4.0M | ||
| Q1 25 | $55.4M | — | ||
| Q4 24 | $84.6M | $5.8M | ||
| Q3 24 | $-9.0M | $4.7M | ||
| Q2 24 | $67.4M | $7.0M | ||
| Q1 24 | $61.9M | $164.0K |
| Q4 25 | $122.4M | — | ||
| Q3 25 | $78.3M | $-2.8M | ||
| Q2 25 | $72.4M | $1.1M | ||
| Q1 25 | $54.6M | — | ||
| Q4 24 | $84.1M | $-1.3M | ||
| Q3 24 | $-9.2M | $-4.5M | ||
| Q2 24 | $67.1M | $-1.6M | ||
| Q1 24 | $61.4M | $-15.2M |
| Q4 25 | 59.6% | — | ||
| Q3 25 | 37.4% | -2.3% | ||
| Q2 25 | 38.5% | 0.9% | ||
| Q1 25 | 30.7% | — | ||
| Q4 24 | 46.2% | -1.1% | ||
| Q3 24 | -5.8% | -3.5% | ||
| Q2 24 | 46.2% | -1.4% | ||
| Q1 24 | 42.3% | -12.2% |
| Q4 25 | 0.3% | — | ||
| Q3 25 | 0.1% | 5.8% | ||
| Q2 25 | 0.0% | 2.4% | ||
| Q1 25 | 0.4% | — | ||
| Q4 24 | 0.3% | 5.8% | ||
| Q3 24 | 0.2% | 7.2% | ||
| Q2 24 | 0.2% | 7.1% | ||
| Q1 24 | 0.4% | 12.3% |
| Q4 25 | 7.25× | — | ||
| Q3 25 | 2.49× | — | ||
| Q2 25 | 6.05× | — | ||
| Q1 25 | 22.92× | — | ||
| Q4 24 | 6.75× | — | ||
| Q3 24 | -0.96× | — | ||
| Q2 24 | 3.44× | — | ||
| Q1 24 | 2.23× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
COLL
Segment breakdown not available.
NDLS
| Food And Beverage | $119.6M | 98% |
| Franchise | $2.5M | 2% |
